# Efficacy of KOVIR Capsule in the Combination Regimen With Background Treatment in COVID-19 Patients

> **NCT05044650** · NA · UNKNOWN · sponsor: **Sao Thai Duong Joint Stock Company** · enrollment: 1000 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DIETARY_SUPPLEMENT:** KOVIR capsule combined with background treatment

## Key facts

- **NCT ID:** NCT05044650
- **Lead sponsor:** Sao Thai Duong Joint Stock Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05044650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05044650, "Efficacy of KOVIR Capsule in the Combination Regimen With Background Treatment in COVID-19 Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05044650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*